Bardoxolone
CDDO is a synthetic oleanane triterpenoid that blocks the cellular synthesis of inducible nitric oxide synthase and inducible COX-2 in INF-γ-activated mouse macrophages with an IC50 value of 0.4 nM. By suppressing reactive oxygen and nitrogen species (ROS/RNS) formation, it promotes the cellular control of ROS/RNS levels that would lead to DNA damage associated with tumorigenesis. In various Y cell lines, CDDO has been shown to specifically inhibit proliferation and induce apoptosis. Mechanism studies revealed that CDDO is a ligand for peroxisome proliferator-activated receptor γ, and also that it induces genes regulated by Nrf2, including heme oxygenase-1 and eotaxin-1, which play a role in antioxidant response element signaling activity.
Catalog Number | T2915 |
Alternative Name(s) | CDDO , RTA 401 |
Research Area | Immunology/Inflammation|||Others |
Molecular Formula | C31H41NO4 |
CAS# | 218600-44-3 |
Purity | 97.90% |
SMILES | C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C1[C@]2(CC[C@@H]2[C@@]1(C=C(C(=O)C2(C)C)C#N)C)C)(C)C)C(=O)O |
Size | 5 mg |
Supplier Page | https://www.targetmol.com/compound/Bardoxolone |
Additional Information | https://www.targetmol.com/datasheet/T2915 |